GlassScriptPhysician profile
Dayna Salasche
NPI 1053377234
$1,762.98
in general payments reported to CMS, 2019-2025
21 companies · $349 in 2025
The $349 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $145 · 2020: $72.09 · 2021: $14.80 · 2022: $513 · 2023: $352 · 2024: $317 · 2025: $349.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,018.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,018.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $617.68 | 2020-2025 | Lo Loestrin Fe, Liletta |
| Coopersurgical, INC. | $154.22 | 2019-2025 | Paragard T 380a, Paragard T 380a |
| Organon LLC | $123.68 | 2022-2025 | Nexplanon, Nuvaring |
| Hologic Sales and Service, LLC | $112.26 | 2019-2025 | Aptima |
| Exeltis, USA INC. | $110.83 | 2024-2025 | Slynd |
| Astellas Pharma US INC | $76.61 | 2024-2025 | Veozah |
| Mayne Pharma Commercial LLC | $68.68 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $65.35 | 2019-2024 | Gardasil 9, Gardasil, Vaxneuvance |
| Bayer Healthcare Pharmaceuticals INC. | $64.63 | 2019-2025 | |
| Millicent US INC | $63.81 | 2025 | Intrarosa, Femlyv, Femring |
| Allergan, INC. | $48.43 | 2019-2020 | |
| Novo Nordisk INC | $41.18 | 2023-2024 | Wegovy |
| Channel Medsystems, INC. | $37.52 | 2022-2023 | |
| Sumitomo Pharma America, INC. | $29.31 | 2023 | Myfembree |
| Myovant Sciences INC. | $27.96 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $27.73 | 2020 | |
| Biogen, INC. | $25.83 | 2025 | Zurzuvae |
| Pfizer INC. | $23.01 | 2024 | |
| Vertical Pharmaceuticals, LLC | $17.51 | 2019 | |
| Lupin INC. | $14.35 | 2019 | |
| Avion Pharmaceuticals | $12.40 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dayna Salasche listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.